<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03871933</url>
  </required_header>
  <id_info>
    <org_study_id>16-029</org_study_id>
    <nct_id>NCT03871933</nct_id>
  </id_info>
  <brief_title>Autonomic Function in COPD and Risk for Atrial Fibrillation</brief_title>
  <official_title>Characterization of Autonomic Function in Patients With Chronic Obstructive Pulmonary Disease - Potential Relevance for Increased Risk of Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the presented study, autonomic function as well as risk for atrial fibrillation will be
      assessed to characterize the relation between risk of atrial fibrillation and autonomic
      function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrial fibrillation (AF) has been suggested as relevant comorbidity in patients with chronic
      obstructive pulmonary disease (COPD). The evaluation of the total atrial conduction time via
      tissue Doppler imaging (PA-TDI interval) can be used to identify patients with increased risk
      of new onset AF. Autonomic function can be assessed by different non invasive clinical
      investigations.

      The investigators hypothesise that PA-TDI interval is increased in acutely exacerbated COPD
      (AECOPD) compared within stable COPD and that increased PA-TDI is related to impairment of
      autonomic function. For this purpose, 25 patients with AECOPD and 25 patients with stable
      COPD were characterized by clinical characteristics, laboratory tests, lung function,
      electrocardiography, echocardiography and autonomic function.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">August 31, 2019</completion_date>
  <primary_completion_date type="Actual">August 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>total atrial conduction time</measure>
    <time_frame>Baseline</time_frame>
    <description>total atrial conduction time via tissue Doppler imaging (PA-TDI interval)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>Baseline</time_frame>
    <description>For the assessment of autonomic function different test that characterize sympathetic or parasympathic function are performed. All tests for autonomic function are non invasive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baroreflex sensitivity</measure>
    <time_frame>Baseline</time_frame>
    <description>For the assessment of autonomic function different test that characterize sympathetic or parasympathic function are performed. All tests for autonomic function are non invasive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chemoreflex sensitivity</measure>
    <time_frame>Baseline</time_frame>
    <description>For the assessment of autonomic function different test that characterize sympathetic or parasympathic function are performed. All tests for autonomic function are non invasive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deep breathing test</measure>
    <time_frame>Baseline</time_frame>
    <description>For the assessment of autonomic function different test that characterize sympathetic or parasympathic function are performed. All tests for autonomic function are non invasive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ewing test</measure>
    <time_frame>Baseline</time_frame>
    <description>For the assessment of autonomic function different test that characterize sympathetic or parasympathic function are performed. All tests for autonomic function are non invasive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cold pressure test</measure>
    <time_frame>Baseline</time_frame>
    <description>For the assessment of autonomic function different test that characterize sympathetic or parasympathic function are performed. All tests for autonomic function are non invasive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cold face test</measure>
    <time_frame>Baseline</time_frame>
    <description>For the assessment of autonomic function different test that characterize sympathetic or parasympathic function are performed. All tests for autonomic function are non invasive.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>AECOPD</arm_group_label>
    <description>acute exacerbation of COPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>stable COPD</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Measurement of lung function, electrocardiography, echocardiography and autonomic function</intervention_name>
    <description>Measurement of lung function, electrocardiography, echocardiography and autonomic function</description>
    <arm_group_label>AECOPD</arm_group_label>
    <arm_group_label>stable COPD</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Collection of 20 ml of peripheral blood Clinical routine such as NTproBNP, renal function,
      thyroid function, blood count
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic obstructive pulmonary disease, exacerbated or stable
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with chronic obstructive pulmonary disease, exacerbated or stable between the
             age of 40-80 years with sinus rhythm who gave informed written consent

        Exclusion Criteria:

          -  Inability to give written consent, acute myocardial infarction with ST-segment
             elevations in last 30 days, severe acute or chronic renal dysfunction, severe heart
             failure, atrial fibrillation, severe valve disease, severe hypotension, active
             malignant disease, active rheumatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>November 7, 2019</last_update_submitted>
  <last_update_submitted_qc>November 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>autonomic function</keyword>
  <keyword>cardiopulmonary interaction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

